Atherosclerosis and Lipoproteins |
From the Department of Pathology (T.S.W.), Institute of Human Nutrition (T.S.W., R.A.J., T.S., R.J.D.), and Department of Pediatrics (R.J.D.), Columbia University, New York, NY.
Correspondence to Dr Tilla S. Worgall, Columbia University, 630 W 168th Street, PH 1512, New York, NY 10032. E-mail tpw7{at}columbia.edu
Objective Sterol-regulatory element-binding proteins (SREBPs) regulate transcription of genes of lipid metabolism. Ceramide decreases transcriptionally active SREBP levels independently of intracellular cholesterol levels. Mechanisms of the ceramide-mediated decrease of SREBP levels were investigated.
Methods and Results Experiments were performed in Chinese hamster ovary cells. Inhibition of ceramide synthesis with myriocin, cycloserine, or fumonisin decreases levels of transcriptionally active SREBP and reduces SRE-mediated gene transcription. When ceramide synthesis is increased through exogenous sphingosine or inhibition of sphingosine kinase, SRE-mediated gene transcription is increased. The important role of ceramide synthesis in SRE-mediated gene transcription is confirmed in LY-B cells that do not synthesize ceramide de novo. LY-B cells fail to increase SRE-mediated gene transcription in sterol depletion.
Conclusions Ceramide synthesis correlates with the generation of transcriptionally active SREBP and SRE-mediated gene transcription. Inhibition of ceramide synthesis decreases levels of transcriptionally active SREBP and SRE-mediated gene transcription. It is hypothesized that the process of ongoing ceramide synthesis contributes to the physiological processing of SREBP, perhaps affecting ER-to-Golgi trafficking. Taken together, modification of ceramide synthesis could be a novel target for drug development in the pharmacologic modification of SRE-dependent pathways.
Key Words: SREBP ceramide myriocin LY-Bsphingosine
This article has been cited by other articles:
![]() |
P. Giussani, L. Brioschi, R. Bassi, L. Riboni, and P. Viani Phosphatidylinositol 3-Kinase/AKT Pathway Regulates the Endoplasmic Reticulum to Golgi Traffic of Ceramide in Glioma Cells: A LINK BETWEEN LIPID SIGNALING PATHWAYS INVOLVED IN THE CONTROL OF CELL SURVIVAL J. Biol. Chem., February 20, 2009; 284(8): 5088 - 5096. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bonzon-Kulichenko, D. Schwudke, N. Gallardo, E. Molto, T. Fernandez-Agullo, A. Shevchenko, and A. Andres Central Leptin Regulates Total Ceramide Content and Sterol Regulatory Element Binding Protein-1C Proteolytic Maturation in Rat White Adipose Tissue Endocrinology, January 1, 2009; 150(1): 169 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bijl, S. Scheij, S. Houten, R. G. Boot, A. K. Groen, and J. M. F. G. Aerts The Glucosylceramide Synthase Inhibitor N-(5-Adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin Induces Sterol Regulatory Element-Binding Protein-Regulated Gene Expression and Cholesterol Synthesis in HepG2 Cells J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 849 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krishnamurthy, S. Dasgupta, and E. Bieberich Development and characterization of a novel anti-ceramide antibody J. Lipid Res., April 1, 2007; 48(4): 968 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J Deckelbaum, T. S Worgall, and T. Seo n-3 Fatty acids and gene expression Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1520 - 1525S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ozbay, A. Rowan, A. Leon, P. Patel, and M. B. Sewer Cyclic Adenosine 5'-Monophosphate-Dependent Sphingosine-1-Phosphate Biosynthesis Induces Human CYP17 Gene Transcription by Activating Cleavage of Sterol Regulatory Element Binding Protein 1 Endocrinology, March 1, 2006; 147(3): 1427 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Park, R. L. Panek, S. B. Mueller, J. C. Hanselman, W. S. Rosebury, A. W. Robertson, E. K. Kindt, R. Homan, S. K. Karathanasis, and M. D. Rekhter Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E-Knockout Mice Circulation, November 30, 2004; 110(22): 3465 - 3471. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |